Pancreatic Acinar Cell Carcinoma Completed Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0040329 (Pancreatic Acinar Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01280058Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic CancerTreatment